HAXS Insider Trading Activity and SEC Form 4 Filings
HAXS insider trading summary
No open-market insider purchases or sales of Healthaxis Inc (HAXS) have been reported on SEC Form 4 in the past 12 months.
Latest HAXS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 30, 2008 | Lewis Asset Management | 10% Owner | Buy | $8K (15,000 @ $0.50) |
| Sep 29, 2008 | Lewis Asset Management | 10% Owner | Buy | $290 (579 @ $0.50) |
| Sep 23, 2008 | Lewis Asset Management | 10% Owner | Buy | $12K (26,000 @ $0.47) |
| Dec 27, 2007 | John W Coyle | Director | Buy | $137 (100 @ $1.37) |
| Dec 27, 2007 | John W Coyle | Director | Buy | $1K (900 @ $1.38) |
| Dec 27, 2007 | Ronald Herbert | Chief Financial Officer | Buy | $6K (5,000 @ $1.10) |
| Dec 27, 2007 | John M Carradine | Chief Executive Officer | Buy | $2K (2,000 @ $1.10) |
| Dec 26, 2007 | John M Carradine | Chief Executive Officer | Buy | $3K (2,200 @ $1.20) |
| Dec 26, 2007 | James J Byrne | Director | Buy | $15K (11,034 @ $1.38) |
| Dec 26, 2007 | Adam J Gutstein | Director | Buy | $1K (1,000 @ $1.30) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.